LQDA Liquidia Corporation
$43.74▲ +2.56%
Healthcare
Other
Pre-market
$43.90▲ +0.36%
Oct 27, 7:43 AM ET
Volume 4.11M
Avg Volume (10D) 6.29M
Key Metrics & Fundamentals
Market Cap
$3.92B
P/E Ratio
31.5
Div Yield
0.00%
52W Range
22.05 - 93.61
% vs 50 MA
-20.95%
% vs 200 MA
-19.22%
RSI-14
50.8
MACD Histogram
+2.7500
Beta (1Y vs SPY)
0.57
Free Cash Flow
$68.01M
Gross Rev
$171.68M
Gross Profit
$160.13M
EBITDA
$88.39M
COGS
$11.55M
Operating Exp
$74.61M
Operating Income
$85.52M
EBIT
$85.52M
Pretax Income
$81.70M
Net Income
$74.72M
EPS (Diluted)
0.74
Price & Volume History
Loading chart…
Recent News
Liquidia Corporation (LQDA) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 26, 2026 9:00 AM ET
Can Liquidia (LQDA) Still Justify Its Price After Settlement?
Simply Wall St. · Oct 24, 2026 8:08 AM ET
United Therapeutics' Tyvaso Outlook Faces Near-Term Pressure After Liquidia Settlement, RBC Says
MT Newswires · Oct 22, 2026 11:35 AM ET
Stocktwits Wall Street Wrap: Crocs, Liquidia Win Upgrades While SpaceX Competition And Grocery Woes Put AST SpaceMobile, Albertsons Under Pressure
Stocktwits · Oct 16, 2026 5:26 AM ET
Why Liquidia (LQDA) Is Up 24.1% After Striking Costly Peace Deal On YUTREPIA Litigation
Simply Wall St. · Oct 15, 2026 9:12 PM ET
How Much Downside Is Left In Liquidia Stock?
Trefis · Oct 14, 2026 9:47 PM ET
Is United Therapeutics (UTHR) Undervalued After Its Legal Settlement?
Simply Wall St. · Oct 14, 2026 9:16 PM ET
United Therapeutics (UTHR) Stock May Be Undervalued Following The Litigation Settlement
Simply Wall St. · Oct 14, 2026 8:14 PM ET
United Therapeutics (UTHR) Settles Litigation And Resets Pulmonary Hypertension Competition
Simply Wall St. · Oct 14, 2026 7:20 PM ET
What to Know as Liquidia, United Therapeutics Settlement Sends LQDA Stock Soaring
Barchart · Oct 14, 2026 4:41 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LQDA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.